Industry News
Pharmaceutical Industry News
AstraZeneca has broken ground on a…
AstraZeneca has broken ground on a $4.5 billion manufacturing facility near Charlottesville, Virginia, confirming a report about its location six weeks ago when state lawmakers approved an economic development package for the project.
Eli Lilly has committed to setting…
Eli Lilly has committed to setting a new standard for onscreen representation of common chronic diseases, and it walked the walk with its recent sponsorship of a segment on “Project Runway.”
The FDA has approved Libtayo as…
The FDA has approved Libtayo as the first immunotherapy for adjuvant treatment of cutaneous squamous cell carcinoma. The nod applies to patients who are at a high risk of recurrence after surgery and radiation.
Lupin expects to invest a combined…
Lupin expects to invest a combined $250 million—covering R&D, infrastructure and capital expenditures over five years—to build a new pharmaceutical production plant in Coral Springs, Florida. The site will focus on the production of respiratory
Xspray has now received three FDA…
Xspray has now received three FDA complete response letters in as many years as it attempts to launch its Dasynoc, a leukemia med based on BMS' blockbuster Sprycel.
Phreesia’s Danielle Lynch…
Phreesia's Danielle Lynch discusses patient engagement at scale
Ferring plans to lay off 500…
Ferring plans to lay off 500 employees, or approximately 7% of its staff, as part of a streamlining effort, the company said in a brief statement.
How agentic AI is transforming…
How agentic AI is transforming market research in the pharmaceutical industry
AI-driven insights, patient…
AI-driven insights, patient support and omnichannel engagement key to future success
Wasserman says…
Wasserman says hyper-personalization and data-driven insights are reshaping pharma marketing
Eying a multiple sclerosis drug…
Eying a multiple sclerosis drug that it has tabbed with peak annual sales potential of $12 billion in the U.S. alone, Zenas BioPharma has struck a licensing deal with China-based InnoCare Pharma that could be
With a pair of new athletic…
With a pair of new athletic partnerships under its belt, Vanda Pharmaceuticals is suiting up as a multisport player.
The U.K. government is in…
The U.K. government is in "advanced talks" with the U.S. and aims to fend off potential tariffs by raising its standard cost-effectiveness threshold for new medicines, according to Politico.
Ahead of ESMO, Astellas shares its…
Ahead of ESMO, Astellas shares its vision to transform cancer care – bringing hope through science to patients living with the hardest-to-treat cancers
Vifor Pharma is letting go of 55…
Vifor Pharma is letting go of 55 employees who report to the Swiss company’s primary U.S. office in King of Prussia, Pennsylvania, just outside Philadelphia, according to a Worker Adjustment and Retraining Notification Act report
A U.S. advertising self-regulatory…
A U.S. advertising self-regulatory body has told Galderma to drop or change a claim about how quickly Nemluvio provides itch relief, triggered by a complaint from competitor Sanofi.
Johnson & Johnson Ordered to Pay $966 Million in Latest Talc Lawsuit
The case involves a California woman who died from mesothelioma, a rare cancer. Her family claimed Johnson and Johnson’s talc powder products were to blame.
Boehringer’s Jascayd is the first…
Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade, following in the footsteps of the company's 2014-approved blockbuster Ofev.
This year has brought a range of…
This year has brought a range of challenges for biopharma companies and their leaders, including on-and-off tariff threats and President Donald Trump's arm-twisting around overseas drug spending. Now, new data show how industry leaders are
Parents Struggle to Find Covid Vaccines for Their Children Amid Regulatory Confusion
Children under 12 need different versions of Covid vaccines, but many pharmacies and pediatricians’ offices aren’t stocking them.